These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 382799)

  • 1. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
    Widder KJ; Senyei AE; Ranney DF
    Adv Pharmacol Chemother; 1979; 16():213-71. PubMed ID: 382799
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetically controlled targeted micro-carrier systems.
    Gupta PK; Hung CT
    Life Sci; 1989; 44(3):175-86. PubMed ID: 2644506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 4. Albumin microspheres as drug carriers.
    Morimoto Y; Fujimoto S
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):19-63. PubMed ID: 3913529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental methods in cancer therapeutics.
    Widder KJ; Senyei AE; Sears B
    J Pharm Sci; 1982 Apr; 71(4):379-87. PubMed ID: 7045329
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic targeting of microspheres in blood flow.
    Driscoll CF; Morris RM; Senyei AE; Widder KJ; Heller GS
    Microvasc Res; 1984 May; 27(3):353-69. PubMed ID: 6727704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
    Morimoto Y; Natsume H
    Nihon Rinsho; 1998 Mar; 56(3):649-56. PubMed ID: 9549351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical drug targeting: magnetically responsive albumin microspheres.
    Senyei AE; Driscoll CF; Widder KJ
    Methods Enzymol; 1985; 112():56-67. PubMed ID: 4046864
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.
    Widder KJ; Senyei AE; Ranney DF
    Cancer Res; 1980 Oct; 40(10):3512-7. PubMed ID: 7438037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
    Widder KJ; Marino PA; Morris RM; Howard DP; Poore GA; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):141-7. PubMed ID: 6682772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Means of increasing the effectiveness of drug therapy of malignant neoplasms].
    Borisov VI; Rusakov IG; Bogdanova NV
    Sov Med; 1986; (6):53-8. PubMed ID: 3529449
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo.
    Iacob G; Rotariu O; Strachan NJ; Häfeli UO
    Biorheology; 2004; 41(5):599-612. PubMed ID: 15477667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
    Kubo T; Sugita T; Shimose S; Nitta Y; Ikuta Y; Murakami T
    Int J Oncol; 2000 Aug; 17(2):309-15. PubMed ID: 10891540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of permanent magnets and magnetic fluids in experimental oncology].
    Barybin AS; Reshchikov VP
    Eksp Onkol; 1985; 7(4):18-22, 71. PubMed ID: 3930206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetically modulated therapeutic systems.
    Häfeli UO
    Int J Pharm; 2004 Jun; 277(1-2):19-24. PubMed ID: 15158965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic microspheres: a vehicle for selective targeting of drugs.
    Widder KJ; Senyei AE
    Pharmacol Ther; 1983; 20(3):377-95. PubMed ID: 6351115
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.